InvestorsHub Logo

Goteleft

05/16/14 10:10 AM

#14855 RE: stockmasterflash #14853

The bid says differant, long and strong.

brent818181

05/16/14 10:49 AM

#14857 RE: stockmasterflash #14853

WOW...seriously...

Goteleft

05/16/14 12:45 PM

#14859 RE: stockmasterflash #14853

stockmasterflash, You have the right to your OPINION, I believe We will see in the future what Dr. Dalton has been doing lately.

Goteleft

07/05/14 4:29 PM

#14913 RE: stockmasterflash #14853

Press release from_what_some call a "non operating shell"


UNIVEC Announces Appointment for Chairman of Financial Advisory Board


Owings Mills, MD, July 03, 2014 --(PR.com)-- Univec, Inc. (UNVC) a specialty pharmaceutical company, announces the appointment for Chairman of the Financial Advisory Board ("CFAB" or "Chairman") Robert M. Cohen of Revolution Investment Management based in New York. Mr. Cohen will be responsible for overseeing operations in finance. With over 32 years in the investment industry Mr. Cohen was Founder and President of Robert M. Cohen and Co., a full service brokerage firm specializing in investment banking , research and marketing making.

David L. Dalton, President and CEO of Univec stated, “We are delighted to have reached this agreement with such a seasoned professional. Mr. Cohen's expertise will lead the company's financial operations and funding process for expanding and moving forward.”

About Univec
Univec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes transdermal patches and high cost Specialty Pharmaceuticals. Recent NDC approvals by the FDA provides a niche market for smoking cessation, nicotine replacement products and pain management along with behavioral health pharmaceuticals.

Forward Looking Statements
This document may contain forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univec’s business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univec’s reports to the General Public and reporting agencies. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univec’s reports filed

Univec Inc.
The Specialty Pharmaceutical Company

Contact:
David Dalton, President




Contact Information
Univec Inc.
David Dalton
443-253-0194
Contact

StealthTrader

07/31/14 7:07 PM

#15104 RE: stockmasterflash #14853

UNIVEC is out of BUSINESS - Non Operating Shell

Univec has NO web site:

www.univec.com is a gibberish site with a mattress?

www.univecinc.com does not exist.

jmho

Read the post from another board member:

_________________________________

UNVC is a non operating shell

UNVC has not operated as a business in nearly 2 years

“The UNVC shell is a "dirty shell" with secured debt from it's toxic lender, Cory Ribotsky's AJW/NIR Group, and 6 figures worth of municipal and federal LIENS against it.

http://casesearch.courts.state.md.us/inquiry/inquiry-index.jsp

Shells can be had for less than $100 grand. No need to pay that PLUS another $600 grand to clear the liens. Doesn't make any rational economic sense. The shell is unsaleable and I doubt anyone has it listed for sale.

That's why the company has been completely silent. The CEO just walked away.

Not hard to find him:

David L. Dalton, RPh

38 Stags Leap Ct, Pikesville, MD 21208
(443) 253-0194”